MYOSLID is involved in the advancement of head and neck squamous cell carcinomas (HNSCC) and osteosarcoma, and its mechanism of action is by promoting RAB13 expression by sponging microRNA-1286 or promoting invasion and metastases by regulating a part of the epithelial-mesenchymal transformation [29, 30]. Here, RAB13 is linked to osteosarcoma.